Charbonnel B, Coornaert S, Tellier J L, Peltier P, Chatal J F
Presse Med. 1984 Mar 31;13(14):863-6.
Meta-iodobenzylguanidine was synthesized, radiolabelled with I 131 or I 123 and injected to 28 controls and 7 patients totalling 13 foci of pheochromocytoma. The tumour was located in one adrenal gland in 3 cases, in both adrenal glands in 1 case, and between the aorta and the vena cava in 1 case; 2 were malignant with metastases. Scintigraphy was negative in all controls, whereas all pheochromocytomas were clearly demonstrated 24 h after injection, except one regarded as non functional due to necrosis. By comparison, CT readily showed the tumour in 7 cases, showed it only thanks to scintigraphic guidance in 4 cases and failed in 2 cases. It is concluded that scintigraphy with meta-iodobenzylguanidine provides a safe and reliable means of locating a wide range of pheochromocytomas.
间碘苄胍经合成后,用碘131或碘123进行放射性标记,并注射到28名对照者和7名患者体内,这些患者共有13个嗜铬细胞瘤病灶。肿瘤位于一侧肾上腺3例,双侧肾上腺1例,主动脉与腔静脉之间1例;2例为恶性并伴有转移。所有对照者的闪烁扫描均为阴性,而除1例因坏死被视为无功能的嗜铬细胞瘤外,所有嗜铬细胞瘤在注射后24小时均清晰显示。相比之下,CT在7例中能轻易显示肿瘤,4例仅在闪烁扫描引导下才显示肿瘤,2例未能显示。结论是,间碘苄胍闪烁扫描为定位多种嗜铬细胞瘤提供了一种安全可靠的方法。